NAD+ 1000mg 30ml vial (IM or IV)

AestheticsRx

IM/IV Vitamin & Wellness Injection

NAD+ Injectable (IM/IV)

Supplied by AestheticsRx Pharma Ltd, a GPhC Registered UK pharmacy (GPhC Reg No. 9012430).
Superintendent Pharmacist listed as Adeel Ahmed (GPhC No. 2233021) on the pharmacy’s legal information.
Product supplied within a prescription Only and professional Use IM/IV vitamins category; no specific MHRA marketing authorisation for NAD+ injection is stated.
Use must comply with UK medicines regulations and local clinical governance for unlicensed or special Order injectable preparations, where applicable.

Supplied by AestheticsRx Pharma Ltd, a GPhC Registered UK pharmacy (GPhC Reg No. 9012430).
Superintendent Pharmacist listed as Adeel Ahmed (GPhC No. 2233021) on the pharmacy’s legal information.
Product supplied within a prescription Only and professional Use IM/IV vitamins category; no specific MHRA marketing authorisation for NAD+ injection is stated.
Use must comply with UK medicines regulations and local clinical governance for unlicensed or special Order injectable preparations, where applicable.

NAD+ Injectable (IM/IV)

Description

NAD+ 1000mg 30ml vial (IM or IV) is a high-strength injectable solution of nicotinamide adenine dinucleotide (NAD+), supplied for intramuscular or intravenous administration by qualified professionals. It is promoted for supporting cellular energy production, mental clarity, cellular repair and general wellness, particularly in adults seeking to address age-related decline in endogenous NAD+ levels. The product is dispensed by AestheticsRx Pharma, a GPhC-registered UK pharmacy, and is intended for professional use only.

Bnefits

Provides a high-strength 1000mg NAD+ solution in a 30ml vial for IM or IV administration by trained professionals.
Supports cellular energy production by contributing to metabolic pathways involved in ATP generation.
Promoted to aid mental clarity, cognitive focus and overall sense of wellbeing.
Marketed as supporting cellular repair, healthy ageing and resilience to cellular stress by raising NAD+ levels.
Allows flexible dosing regimens for both intramuscular and intravenous use within stated weekly and monthly limits.
Supplied by a GPhC-registered UK pharmacy specialising in IM/IV wellness and aesthetic medications.

Indications

Professional-use NAD+ injectable solution for adults as part of IM or IV wellness protocols where NAD+ supplementation is deemed appropriate by a prescriber.
Intended to support cellular energy production, recovery, cognitive function and general wellness in individuals with perceived or suspected reduced NAD+ levels.
Use only under the direction and supervision of a suitably qualified prescriber and in accordance with local clinical governance and regulatory requirements.

Composition

Active ingredient: Nicotinamide Adenine Dinucleotide (NAD+) 1000mg per 30ml vial.
Concentration: approximately 33.3mg/ml NAD+ (assuming 1000mg in 30ml).
Other excipients: not publicly specified (likely sterile aqueous solution with buffering agents as per manufacturer’s specification; details not listed by the pharmacy).

Formulation

Pharmaceutical form: solution for injection.
Presentation: multidose 30ml glass vial containing 1000mg NAD+ for IM or IV administration.
Route of administration: intramuscular (IM) or intravenous (IV) injection/infusion by trained healthcare professionals only.
Intended use: prescription-only, clinic-based wellness and metabolic support treatment as part of supervised protocols.
Preservatives, pH and osmolarity: not publicly specified on the pharmacy product page.

Packaging

Single 30ml multidose vial containing a total of 1000mg NAD+.
Vial supplied in professional packaging suitable for cold-chain storage in a clinical environment.
Product information and dosing guidance available on the AestheticsRx Pharma product page; any additional labelling is as per pharmacy and manufacturer requirements.

Usage

For professional use only; administration should be carried out by suitably trained healthcare practitioners in appropriate clinical settings.
NAD+ dosing must always be individualised based on patient factors, clinical judgement and local guidelines; the following reflects the pharmacy’s general guidance and is not a substitute for medical advice.
Recommended dosages – Intramuscular (IM):
• Starting dose 25–50mg per IM administration.
• Increase in 25mg increments if the client tolerates treatment.
• Maximum IM dose is 100mg per administration.
• Maximum weekly IM dose is 200mg.
• Total combined IM and IV weekly dose must not exceed 500mg.
Recommended dosages – Intravenous (IV):
• Start with 25mg per IV infusion.
• Infusion rate guidance: approximately 35 drops per minute (as per pharmacy information).
• Maximum dose is 250mg NAD+ per IV infusion.
• Maximum weekly IV dose is 500mg (e.g. 2 x 250mg infusions per week).
• Maximum monthly NAD+ dose is 1000mg (e.g. 4 x 250mg infusions in a month).
Monitor patients for tolerance, blood pressure, heart rate and any adverse effects during and after administration.
NAD+ injections should not be given to self-medicating individuals without proper assessment; use must follow the prescriber’s protocol and local regulations.
Do not exceed recommended weekly or monthly cumulative doses without specialist supervision.
Do not use the product if the solution appears discoloured, cloudy, contains particulates, the vial is damaged or the product is out of date.

Contraindications

Pregnancy or breastfeeding (use is specifically advised against for pregnant or breastfeeding women).
Current cancer or history of cancer (patients with active or prior cancer are advised not to use this product).
Known autoimmune diseases (the supplier advises against use in people with autoimmune conditions).
Patients taking certain medications such as chemotherapy agents, immunosuppressants or medicines that significantly affect cellular metabolism, unless cleared by a prescribing clinician.
Uncontrolled or very high blood pressure and significant heart conditions, unless under specialist supervision and explicit medical approval.
Known hypersensitivity to NAD+ or any excipient in the formulation (if previously identified).
Any other serious medical condition where NAD+ injection is not recommended by a qualified healthcare professional.
Use in individuals without prior medical assessment or in non-clinical settings is not recommended.

Adverse Effects

According to the supplier, NAD+ supplements and boosters (including NMN and NR) are generally well-tolerated at typical doses, but some people may experience:
• Nausea.
• Fatigue or transient tiredness.
• Headache.
• Digestive discomfort such as bloating, diarrhoea or stomach cramps.
• Flushing, described as a warm, red feeling (particularly at higher doses or with some nicotinamide-related compounds).
Most reported side effects are described as mild and often resolve as the body adjusts.
Any significant or persistent adverse effects should prompt discontinuation of treatment and review by a healthcare professional.
As with any injectable therapy, there is also a general risk of injection-site reactions, infection, thrombophlebitis (for IV), vascular complications or systemic reactions if not administered properly.

Storage Conditions

Store the vial in a refrigerator at 2–8°C at all times, including after opening.
Maintain cold-chain storage during transport and clinic handling where possible.
Use within 30 days of first opening the vial, discarding any unused solution after this period.
Keep the vial in its original packaging to protect from light and physical damage.
Do not freeze; discard if accidentally frozen.
Keep out of the sight and reach of children.
Do not use beyond the expiry date printed on the vial or outer packaging.

Duration

Duration of therapy depends on individual protocols and clinical response. The supplier\u2019s guidance states a maximum weekly total of 500mg (combined IM and IV) and a maximum monthly total of 1000mg (for example, 4 infusions of 250mg in a month). Ongoing treatment frequency and duration should be reviewed regularly by the prescriber.

Onset

Subjective effects such as changes in energy or mental clarity may occur over the course of initial IM or IV sessions, but onset and magnitude of response vary between individuals. No specific onset-of-action time is stated by the supplier.